These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 17899489)
21. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy. Jazirehi AR Anticancer Drugs; 2010 Oct; 21(9):805-13. PubMed ID: 20679890 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic biomarkers for human cancer: the time is now. Mulero-Navarro S; Esteller M Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583 [TBL] [Abstract][Full Text] [Related]
24. Epigenetic therapies reach main street. Bates SE Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089 [No Abstract] [Full Text] [Related]
25. DNA demethylating agents and epigenetic therapy of cancer. Mani S; Herceg Z Adv Genet; 2010; 70():327-40. PubMed ID: 20920754 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic cancer therapy makes headway. Mack GS J Natl Cancer Inst; 2006 Oct; 98(20):1443-4. PubMed ID: 17047192 [No Abstract] [Full Text] [Related]
27. HDAC modulation and cell death in the clinic. Dell'Aversana C; Lepore I; Altucci L Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671 [TBL] [Abstract][Full Text] [Related]
29. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A; Altucci L Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076 [TBL] [Abstract][Full Text] [Related]
31. Cancer treatment of the future: inhibitors of histone methyltransferases. Spannhoff A; Sippl W; Jung M Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic mechanisms in AML - a target for therapy. Oki Y; Issa JP Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243 [TBL] [Abstract][Full Text] [Related]
35. Unraveling the epigenetic code of cancer for therapy. Smith LT; Otterson GA; Plass C Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396 [TBL] [Abstract][Full Text] [Related]
36. DNA methylation and cancer. Das PM; Singal R J Clin Oncol; 2004 Nov; 22(22):4632-42. PubMed ID: 15542813 [TBL] [Abstract][Full Text] [Related]
37. Targeting aberrant chromatin structure in colorectal carcinomas. Konishi K; Issa JP Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246 [TBL] [Abstract][Full Text] [Related]
38. [Epigenome and cancer: new possibilities of cancer prevention and therapy?]. Paluszczak J; Baer-Dubowska W Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168 [TBL] [Abstract][Full Text] [Related]
39. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. Lyko F; Brown R J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563 [TBL] [Abstract][Full Text] [Related]
40. Epigenetic changes in cancer and preneoplasia. Herman JG Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]